Growth spurs NMC to raise full-year core earnings view

London-listed NMC Health has raised its full-year core earnings view following solid performance the second half of 2018, predicting ‘strong organic growth’ will continue next year. The United Arab Emirates-based healthcare group expects revenue will grow by 2% to 24% in 2019. NMC has increased EBITDA guidance from $465m to $480m for the end of…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »